The major histocompatibility complex (MHC) antigens, HLA antigens in man, are of fundamental importance in generating, regulating, and effecting an immune response to foreign antigens. Products of the class II genes, as well as the associated invariant chain, are expressed primarily on the surfaces of B lymphocytes, macrophages, but now have been observed on many other types of cells. Although class II antigens are known to participate in antigen presentation and regulation in the immune response, and probably also as signals for differentiation, their functions are not completely understood. Regulation of class II genes must be finely tuned. Aberrant or imbalanced class II expression may trigger several autoimmune diseases and may help malignant cells evade an immune response. We propose experiments to identify regulatory genes required for class II expression using somatic cell genetics. In addition, we will investigate the nature of controls of transcription and processing of the class II products. Because different tissue types may use varying mechanisms to regulate class II genes, we will analyze class II expression in the B lymphoid cells and in several cell lines derived from metastatic melanomas which regulate class II expression in different ways. These systems were chosen because they should allow us to compare regulation in two distinct cell lineages and help us determine how controls are abrogated in disease states. At least three subgroups of homologous genes are encoded in the HLA class II region, and several of the genes for well characterized class Ii antigens, DP, DQ, and DR, have been cloned and analyzed. We will compare the mechanisms which control regulation at each sublocus. In addition, new genes, such as DZ, DO, and DX, have been found; and it is possible that there are other genes that are not yet identified within the class II region. Our analysis of the tissue distribution of each class II sublocus product, and examination of their differential regulation, will lead to a better understanding of the mechanisms of eukaryotic gene regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29GM039698-05
Application #
3466897
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1988-02-01
Project End
1993-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Bannish, G; Hume, C; Lee, J S (1996) Coordinate regulation of HLA class II genes: a novel DNA binding complex. Mol Immunol 33:407-15
Mattioni, T; Hume, C R; Konigorski, S et al. (1992) A cDNA clone for a novel nuclear protein with DNA binding activity. Chromosoma 101:618-24
Seidl, C; Saraiya, C; Osterweil, Z et al. (1992) Genetic complexity of regulatory mutants defective for HLA class II gene expression. J Immunol 148:1576-84
Kambhu, S; Falldorf, P; Lee, J S (1990) Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc Natl Acad Sci U S A 87:4927-31
Hume, C R; Lee, J S (1990) Genetics of HLA class II regulation. Immunol Res 9:93-102
Hume, C R; Lee, J S (1990) Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro. Tissue Antigens 36:108-15
Hume, C R; Lee, J S (1989) Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum Immunol 26:288-309